Partner Christopher Cain said the Jumpstart Our Business Startups (JOBS) Act will potentially create a diverse investor base that makes non-venture capital funding an effective option for biopharma startups trying to raise money. Cain also said the JOBS Act’s crowdfunding provision can help biopharmas raise supplementary funds for clinical trials, patent applications and company growth that may attract additional investments.
Click here to read the complete article.
People
Related News
01 January 2025
In the News
Lauren Loew Highlights Illinois Genetic Privacy Law as Topic to Watch in 2025
Foley & Lardner LLP partner Lauren Loew highlighted the ongoing legal wrangling over Illinois' Genetic Information Privacy Act (GIPA) in the Law360 article, "Illinois Cases To Watch In 2025."
01 January 2025
In the News
Dennis Cardoza Highlights Key Energy Policy Focuses in 2025
Foley & Lardner Public Affairs Director Dennis Cardoza discussed key energy policy focuses for the new year in the Law360 article, "Top 5 Energy Policy Areas To Watch In 2025."
01 January 2025
In the News
Jeffery Atkin Shares Insight on Energy Sector Trends for 2025
Foley & Lardner LLP partner Jeffery Atkin shared perspective on energy sector trends for the year ahead in the Law360 article, "5 Energy Transactional Trends To Watch In 2025."